We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Heparin Could Reduce Neurologic Deterioration Following Stroke

By HospiMedica International staff writers
Posted on 27 Aug 2012
Following an acute ischemic stroke, low-molecular weight heparin (LMWH) may help prevent early neurologic deterioration in patients with large artery occlusive disease (LAOD), according to a new study. More...


Researchers at the Prince of Wales Hospital (Hong Kong SAR, China) conducted a post-hoc analysis of a randomized, controlled, trial involving 353 patients following acute ischemic stroke and LAOD. The patients were randomly assigned to receive either subcutaneous LMWH (180 patients) or oral aspirin (173 patients) within 48 hours after stroke onset for 10 days; following intervention, all patients received aspirin once daily for six months. The main outcome measure was the prevention of early neurologic deterioration (END) within the first 10 days after index stroke.

The analysis showed that END occurred in 12 of the heparin group patients (6.7%) and 24 of the aspirin group patients (13.9%). The 7.2 percentage point difference yielded an odds ratio of 0.44 in favor of heparin. When the researchers looked at the individual components of their endpoint, they found that stroke progression within the first 10 days was 5% with heparin and 12.7% with aspirin, leading to an odds ratio of 0.36. The rates of early recurrent ischemic stroke (ERIS) and intracranial cerebral hemorrhage were not significantly different, as were the rates of other cerebral hemorrhages, both symptomatic and asymptomatic. The study was published in the August 13, 2012, issue of Archives of Neurology.

“For patients with acute ischemic stroke and LAOD, treatment with LMWH within 48 hours of stroke may reduce END during the first 10 days, mainly by preventing stroke progression,” concluded lead author Ka Sing Lawrence Wong, MD, and colleagues. “The similar rate of cerebral hemorrhage between LMWH and aspirin demonstrated that LMWH may be safely used in acute ischemic stroke.”

Patients with acute ischemic stroke and LAOD have an increased risk for early neurologic deterioration due to progressive stroke, ERIS, or symptomatic intracranial cerebral hemorrhage (SICH). LMWH has been widely advocated to prevent venous thromboembolism, but its risks and benefits in early ischemic stroke are inadequately defined.

Related Links:

Prince of Wales Hospital




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.